APA (7th ed.) Citation

A, G., M, P., T, S., G, C., H, T., R, R., . . . JP, C. (2021). Low doses of methylnaltrexone inhibits head and neck squamous cell carcinoma growth in vitro and in vivo by acting on the mu-opioid receptor. Journal of cellular physiology, 236(11), 7698. https://doi.org/10.1002/jcp.30421

Chicago Style (17th ed.) Citation

A, Gorur, et al. "Low Doses of Methylnaltrexone Inhibits Head and Neck Squamous Cell Carcinoma Growth in Vitro and in Vivo by Acting on the Mu-opioid Receptor." Journal of Cellular Physiology 236, no. 11 (2021): 7698. https://doi.org/10.1002/jcp.30421.

MLA (9th ed.) Citation

A, Gorur, et al. "Low Doses of Methylnaltrexone Inhibits Head and Neck Squamous Cell Carcinoma Growth in Vitro and in Vivo by Acting on the Mu-opioid Receptor." Journal of Cellular Physiology, vol. 236, no. 11, 2021, p. 7698, https://doi.org/10.1002/jcp.30421.